BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webster, L.
Right arrow Articles by Limb, G A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webster, L.
Right arrow Articles by Limb, G A.
Br J Ophthalmol 1998;82:438-443 ( April )

Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment

Lynne Webster, Ros M Stanbury, Anthony H Chignell, G Astrid Limb

Department of Ophthalmology, The Rayne Institute, UMDS, St Thomas's Hospital, London

Correspondence to: Dr G A Limb, Retinal Inflammation Laboratory, Department of Ophthalmology, Rayne Institute, St Thomas's Hospital, London SE1 7EH.

Accepted for publication 6 November 1997

AIMS---The vitreous levels of soluble intercellular adhesion molecule 1 (sICAM-1) were investigated in uveitic eyes undergoing vitrectomy for retinal detachment (RD) or other complications, and the presence of this molecule was related to disease activity and vitreous levels of the cytokine tumour necrosis factor alpha  (TNFalpha ), known to upregulate ICAM-1 expression on various cells.
METHODS---Vitreous and serum samples from 23 patients with either active or quiescent uveitis undergoing retinal surgery were examined for the levels of immunoreactive sICAM-1 and TNFalpha by ELISA methods, and for the presence of biologically active TNFalpha . Vitreous from non-uveitic eyes with rhegmatogenous retinal detachment (RRD), macular holes or cadaveric eyes were used as controls.
RESULTS---As a whole, vitreous from uveitic eyes complicated or uncomplicated by RRD contained significantly higher levels of sICAM-1 than vitreous from non-uveitic eyes with RRD alone (p < 0.0005), eyes with macular holes (p< 0.0001), or normal cadaveric vitreous (p < 0.0001). The proportion of vitreous containing >20 ng/ml sICAM-1 (> four times the normal values) was significantly higher in eyes with uveitis complicated by RRD than in those eyes without RRD (Fisher's test, p= 0.02), and although levels of sICAM-1 were higher in eyes with active uveitis than in those with quiet disease (p < 0.02), this could not be dissociated from the increase caused by RRD. There was a relation between the vitreous levels of sICAM-1 and those of immunoreactive TNFalpha (Spearman's correlation coefficient; r = 0.601, p = 0.006), but not between the vitreous levels of sICAM-1 and those of biologically active TNFalpha .
CONCLUSION---Increased vitreous sICAM-1 levels and the association of this molecule with the presence of immunoreactive TNFalpha in uveitic eyes confirm the operation of cytokine mediated vascular reactions at the blood-retinal barrier during the development of this condition. The persistence of high vitreous levels of sICAM-1 in eyes with uveitis complicated by RRD despite previous immunosuppression may indicate a low rate of clearance of inflammatory molecules from the vitreous cavity and an exacerbation of the existing inflammatory process by the retinal detachment itself.

Keywords: vitreous; retinal detachment; ICAM-1; TNFalpha ; uveitis


© 1998 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
IOVSHome page
G. A. Limb, J. Hickman-Casey, R. D. Hollifield, and A. H. Chignell
Vascular Adhesion Molecules in Vitreous from Eyes with Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2453 - 2457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 by the BMJ Publishing Group Ltd.